Celltrion
068270.KS
#761
Rank
A$42.77 B
Marketcap
$198.76
Share price
-0.28%
Change (1 day)
-3.72%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: A$42.77 Billion

As of February 2025 Celltrion has a market cap of A$42.77 Billion. This makes Celltrion the world's 761th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025A$42.77 B0.81%
2024A$42.42 B-13.67%
2023A$49.14 B84.45%
2022A$26.64 B-16.7%
2021A$31.98 B-45.46%
2020A$58.64 B106.2%
2019A$28.43 B-19.33%
2018A$35.25 B6.93%
2017A$32.97 B118.62%
2016A$15.08 B35.93%
2015A$11.09 B150.71%
2014A$4.42 B10.66%
2013A$3.99 B-4.36%
2012A$4.18 B17.42%
2011A$3.56 B4.93%
2010A$3.39 B131.18%
2009A$1.46 B28.41%
2008A$1.14 B5250%
2007A$21.36 M

End of Day market cap according to different sources

On Jan 31st, 2025 the market cap of Celltrion was reported to be:

A$42.77 Billion
by Yahoo Finance info icon info icon
A$42.77 Billion
by CompaniesMarketCap info icon info icon